Skip to main content
. 2023 Oct 3;14:1207943. doi: 10.3389/fendo.2023.1207943

Table 3.

HR (95% CIs) for all-cause and cause-specific mortality according to serum 25(OH)D concentrations among participants with kidney stones.

Serum 25(OH)D concentrations (nmol/L) P for trend
<25 25-49.9 50-74.9 ≥75
All-cause mortality
Number of deaths (%)
Model 1
HR (95% CI) P
Model 2
HR (95% CI) P
Model 3
HR (95% CI) P
19 (19.2)
Reference

Reference

Reference
79 (11.8)
0.58 (0.35, 0.95) 0.03

0.56 (0.32, 0.99) 0.04

0.62 (0.34, 1.13) 0.12
142 (12.9)
0.65 (0.40, 1.05) 0.08

0.60 (0.34, 1.03) 0.06

0.63 (0.35, 1.13) 0.12
135 (12.9)
0.69 (0.43, 1.12) 0.13

0.50 (0.29, 0.87) <0.01

0.48 (0.26, 0.87) 0.02

0.68

0.04

0.02
CVD mortality
Number of deaths (%)
Model 1
HR (95% CI) P
Model 2
HR (95% CI) P
Model 3
HR (95% CI) P
7 (7.1)
Reference

Reference

Reference
20 (3.0)
0.96 (0.40, 2.31) 0.92

0.84 (0.28, 2.52) 0.76

0.55 (0.16, 1.95) 0.36
32 (2.9)
0.59 (0.25, 1.38) 0.23

0.52 (0.17, 1.61) 0.25

0.21 (0.05, 0.85) 0.03
24 (2.3)
1.21 (0.51, 2.85) 0.67

1.29 (0.40, 4.21) 0.67

0.91 (0.23, 3.63) 0.89

0.58

0.27

0.68
Cancer mortality
Number of deaths (%)
Model 1
HR (95% CI) P
Model 2
HR (95% CI) P
Model 3
HR (95% CI) P
7 (7.1)
Reference

Reference

Reference
13 (2.0)
0.76 (0.21, 2.70) 0.67

0.68 (0.12, 3.72) 0.65

0.67 (0.12, 3.78) 0.65
20 (1.8)
0.45 (0.13, 1.58) 0.21

0.23 (0.05, 1.02) 0.05

0.33 (0.07, 3.78) 0.64
39 (3.7)
0.45 (0.13, 1.52) 0.20

0.20 (0.05, 0.82) 0.03

0.32 (0.07, 1.42) 0.13

0.08

0.02

0.08

Model 1: Non-adjusted model.

Model 2: Adjusted for age, gender, race, BMI, educational attainment, leisure-time physical activity, marital status, family poverty ratio, smoking status, and alcohol status.

Model 3: Adjusted for age, gender, race, BMI, educational attainment, leisure-time physical activity, marital status, family poverty ratio, smoking status, alcohol status, diabetes, hypertension, stroke chronic kidney disease, cancer, and cardiovascular disease.